All Articles

DecisionHR hires PEO veteran Josh McIntosh as CRO, signaling a strategic push for market share in the booming, competitive HR outsourcing industry.

Freshly spun-off from AnaptysBio, First Tracks Biotherapeutics hits the market with a strong cash position and a pipeline aimed at celiac disease and RA.

UAB Kvartalas completes its flagship office project but reports €3.5M in losses, calling a critical meeting as a €40.6M bond payment deadline nears.

As cyber threats loom, Rpharmy's SOC 2 Type II audit signals a deep commitment to protecting sensitive patient data and ensuring system reliability.

As crypto traders drown in data, DSCVR's new AI subscription promises to turn noise into actionable intelligence. Is this the future of Web3 investing?

As leaders gather for the 70th OSUM conference, 'strong mayor' powers, homelessness, and the upcoming election dominate a high-stakes agenda.

ModMed's acquisition of Bonsai Health signals a new era of autonomous AI, promising to automate practice workflows and reshape patient engagement at scale.

As pay transparency and economic pressures mount, a new unified platform aims to democratize compensation intelligence across the entire organization.

A new deal between Edly and Pilotbase offers income-based loans to aspiring pilots, tackling the high cost of training to fill a critical industry gap.

ATCC and the Broad Institute unveil engineered lung cancer cells to decode drug resistance, offering new hope for patients and fueling AI-driven discovery.

Atsena Therapeutics gets the green light for the final trial phase of a promising gene therapy, offering the first real hope for patients with X-linked retinoschisis.

The 15-year partnership between Kia and TotalEnergies is renewed, focusing on cutting-edge lubricants and solutions for the growing EV market.

Bahamas Grid Company appoints a new Bahamian CEO and CFO, marking a historic transition to full local leadership after a major $130M grid upgrade.

New real-time system brings lab-grade oil analysis onboard ships and industrial sites, promising to slash downtime and transform asset maintenance.

Tenvie Therapeutics begins human trials for TNV108, a drug that targets the root cause of nerve decay, offering a potential disease-modifying breakthrough.

Developer Cole West announces Lone Tree, a 38-home community in Syracuse, answering high demand with homes from the $700Ks and a unique focus on local history.

AHIP secures major financial savings and operational freedom in a deal to end its management contract with Aimbridge, but the path to a new future is complex.

As the fiber market booms, one brand's two-decade success reveals a powerful link between regenerative agriculture, consumer trust, and digestive wellness.

The B2B media giant expands its data-driven model to the UK's lucrative financial services sector, leveraging AI-era content strategies for growth.

With a new world-class exploration VP and a bullish gold market, Blossom Gold is aggressively pushing to unlock a 1.28M ounce gold deposit in Nevada.